Effectiveness of combined omega-3 polyunsaturated fatty acids with dietary nutrition in patients with non-alcoholic fatty liver disease

Guo-ying ZHU,Dong-ping HUANG,Jian-wei HUANG,Chang-qing YANG,Feng-shang ZHU
DOI: https://doi.org/10.16118/j.1008-0392.2017.02.016
2017-01-01
Abstract:Objective To assess the effectiveness of combined Omega-3 polyunsaturated fatty acids (ω-3 PUFA) with dietary nutrition in patients with non-alcoholic fatty liver disease (NAFLD).Methods One hundred and twenty-eight patients with NAFLD were enrolled in this 24-week randomized controlled trial.Patients in group A (n =59) received strict diet control and aerobic exercise,and those in group B (n =69) received ω-3 PUFA 6 g/day in addition to the same dies as in group A.The symptom scores,liver function,serum lipid levels and HOMA-insulin resistance index (HOMA-IRI) were assessed after 12 and 24 weeks of treatment.Hepatic fat infiltration and NAFLD activity score(NAS) were determined after 24 weeks of treatment by abdominal CT scan and hepatic pathology,respectively.Results One hundred and eighteen patients (55 in group A,63 in group B) completed the study.After 24 weeks of treatment,the total symptom scores(1.01 ± 1.78 vs 0.97 ± 1.12,P =0.001),alanine aminotransferase (ALT),gamma-glutamyl transpeptidase (GGT),triglyceride(TG) and HOMA-IRI levels were more significantly decreased in group B than those in group A (P < 0.05).Additionally,as compared with the group A (median 5.2 vs 3.6,P =0.008),NAS in group B (median 5.4 vs 2.9,P =0.004) achieved a substantial improvement,but there was no a statistical reduction in fibrosis scores in the two groups.Group B resulted in a significant improvement of fatty liver degree as demonstrated by CT scan.Conclusion A combination of ω-3 PUFA with dietary nutrition demonstrates more marked improvement in symptom scores,liver function,serum lipid levels,HOMA-IRI and hepatic pathology.
What problem does this paper attempt to address?